Cohance Lifesciences: FDA warning letter citing finished pharmaceutical adulteration Jan 2026
February 14, 2026 • Ekalavya Hansaj
Executive Summary: The January 2026 FDA Warning Letter to Cohance Lifesciences REPORT DATE: February 14, 2026 SUBJECT: Regulatory Non-Compliance and Finished Pharmaceutical Adulteration at Nacharam…